Yong Jin

Yong Jin


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2025 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
DWDi Wang
Di Wang
LZLinzhu Zhang
Linzhu Zhang
JNJihu Nie
Jihu Nie
NYNailin Yang
Nailin Yang
SSShumin Sun
Shumin Sun
LCLiang Cheng
Liang Cheng

1 November 2018 in Clinical Radiology
Verified
Journal Article
Closed access
XSX. Sun
X. Sun
JXJ. Xu
J. Xu
JZJ. Zhang
J. Zhang
YJYong Jin
Yong Jin
QCQ. Chen
Q. Chen

1 February 2019 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
XSXingwei Sun
Xingwei Sun
JXJin Xu
Jin Xu
RXRui Xia
Rui Xia
CWCaishan Wang
Caishan Wang
ZYZiyang Yu
Ziyang Yu
YJYong Jin
Yong Jin

11 December 2019 in BMC Surgery
Verified
Journal Article
Open access
PDF file
XSXingwei Sun
Xingwei Sun
XBXuming Bai
Xuming Bai
JSJiaofeng Shen
Jiaofeng Shen
ZYZiyang Yu
Ziyang Yu
ZZZhixiang Zhuang
Zhixiang Zhuang
YJYong Jin
Yong Jin
To compare the efficacy and safety of right internal jugular vein (IJV) approach and right innominate vein (INV) approach for US-guided totally implantable venous access devices (TIVADs), and to explore the advantages and disadvantages of the two approaches. Six hundred and nineteen adult patients had long-term infusion and chemotherapy needs and inconvenience of peripheral venous infusion. Right INV approach was used to implant 339 cases of TIVADs, and right IJV approach was used to implant 280 cases of TIVADs. The success rate of one-time catheterization and the incidence of complications in the two groups were retrospectively analyzed. All patients were successfully implanted in TIVAD. The success rates of one-time puncture in INV group and IJV approach group were 98.53% (334/339) and 95.36% (267/280), respectively. There was significant difference between the two groups (P = 0.020). The incidence of perioperative complications and long-term complications in the right INV group were 1.18% (4/339) and 3.54% (12/339), respectively, while those in the right IJV group were 1.43% (4280) and 3.93% (11280). There was no significant difference in the incidence of perioperative or long-term complications between the two groups (P = 0.785, P = 0.799, respectively). US-guided TIVADs via the right INV approach and the right IJV approach are both safe and reliable. The right INV approach improves the one-time puncture success rate, as long as the technique is properly operated, serious complications rarely occur.

1 December 2018 in Medicine
Verified
Journal Article
Open access
RXRui Xia
Rui Xia
XSXingwei Sun
Xingwei Sun
XBXuming Bai
Xuming Bai
YZYubin Zhou
Yubin Zhou
JSJianming Shi
Jianming Shi
QCQian Chen
Qian Chen
Central venous catheter (CVC) insertion is difficult to perform and is a high-risk operation; ultrasound (US)-guided cannulation helps increase the odds of success while reducing the associated complications. The internal jugular vein (IJV) and subclavian vein (SCV) are the most commonly sites in US-guided CVC insertion. In the present study, we evaluated the safety and efficacy of US-guided supraclavicular right brachiocephalic vein (BCV) cannulations in adult patients. Between January 2016 and December 2017, 428 adult patients requiring 536 CVC insertions underwent ultrasound-guided right BCV cannulation. The success rate and complications related to indwelling catheters were analyzed. The technical success rate was 98.32% (527/536). The procedure was successful at the first try in 511 cases (95.34%). The mean operation time was 13.26 ± 3.34 minutes. The mean length of catheter introduction was 13.57 ± 3.53 cm. Incidence of intraoperative complications was 2.61%. For 3 patients, the procedure was terminated due to pneumothorax (PNX), and in 11 arterial punctures there were self-limiting hematomas. The incidence of postprocedure complications was 5.97% (32/536). These complications included catheter-related infections (n = 18) and thromboses (n = 14). Insertion lasted an average of 10.68 ± 8.77 days. Supraclavicular, in-plane, US-guided cannulation of the right BCV is an effective and safe method for inserting central venous catheters in adult patients. It provides another option for catheter access to boost clinical performance in central venous catheterization.

1 February 2021 in Therapeutics and Clinical Risk Management
Verified
Journal Article
Open access
PDF file
ZYZepeng Yu
Zepeng Yu
XSXingwei Sun
Xingwei Sun
XBXuming Bai
Xuming Bai
WDWei Ding
Wei Ding
WWWeiDong Wang
WeiDong Wang
YJYong Jin
Yong Jin
Purpose: The totally implantable venous access port (TIVAP) provides patients with safe, effective and long-term convenient venous access for the administration of medications such as chemotherapy drugs. The implantation and long-term use of TIVAP are related to thrombosis, infection and other complications. In this study, the medical records of multicentre patients were collected, and the perioperative and postoperative complications were retrospectively analysed to objectively evaluate the safety of the implantation of supraclavicular, ultrasound-guided TIVAP via the brachiocephalic vein (BCV). Patients and Methods: We retrospectively analysed the clinical data of 433 adult patients who had undergone ultrasound-guided TIVAP implantation via the BCV at four hospitals in China from March 2018 to May 2019. The success rates of the first puncture, operation time, and perioperative and postoperative complications were analysed. Results: All the TIVAPs were implanted successfully (100%). The average TIVAP carrying time was 318.15 ± 44.22 days (range: 38– 502 days) for a total of 197,694 catheter days. The success rate of the first puncture was 94.92% (411/433), and the average operation time was 29.66 ± 7.45 min (range: 18– 60 min). The perioperative complications included arterial puncture in 4 patients and pneumothorax in 1 patient. The incidence of postoperative complications was 5.08% (22/433), including poor incision healing (n = 2), catheter-related infection (n = 3), port infection (n = 6), thrombosis (n = 2) and fibrin sheath formation (n = 8). Another patient had infusion disturbance 2 days after the operation, and chest X-ray showed bending at the connection between the catheter and port. No other serious complications occurred, such as catheter rupture and drug leakage. The total incidence of complications was 6.24% (27/433). Conclusion: This study showed excellent tolerance of supraclavicular, ultrasound-guided BCV puncture to implant TIVAP and a low incidence of complications. As a safe and effective method of TIVAP implantation, it can provide a new choice for clinicians.